Author

Rebecca K. Senter

Observed names: R. Senter, R.K. Senter, Rebecca K Senter, Rebecca Senter

Institution: Vertero Therapeutics (United States)

Observed institutions: Vanderbilt University, Flexion Therapeutics (United States), Vertero Therapeutics (United States), Massachusetts Institute of Technology, Vanderbilt University Medical Center

ORCID: 0000-0001-5650-1187

Observed ORCID: 0000-0001-5650-1187

OpenAlex ID: A5022956334

mGlu 7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome

2017 · Rocco G. Gogliotti, Rebecca K. Senter, et al. · Science Translational Medicine · 82

β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X

2017 · Laura J. Stoppel, Benjamin D. Auerbach, et al. · Cell Reports · 67

PDF

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome

2020 · Patrick K. McCamphill, Laura J. Stoppel, et al. · Science Translational Medicine · 61

mGlu 5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome

2016 · Rocco G. Gogliotti, Rebecca K. Senter, et al. · Human Molecular Genetics · 61

PDF

mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence

2021 · David C Stoppel, Patrick K McCamphill, et al. · Frontiers in Psychiatry · 42

PDF

Efficacy and Safety of FX201, a Novel Intra-Articular IL-1Ra Gene Therapy for Osteoarthritis Treatment, in a Rat Model

2021 · Rebecca Senter, Rogely Boyce, et al. · Human Gene Therapy · 29

PDF

Differential activity of mGlu7 allosteric modulators provides evidence for mGlu7/8 heterodimers at hippocampal Schaffer collateral-CA1 synapses

2022 · Xin Lin, Nicole M. Fisher, et al. · Journal of Biological Chemistry · 22

PDF

The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies

2016 · Rebecca K. Senter, Ayan Ghoshal, et al. · Current Neuropharmacology · 20

PDF

Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation

2017 · Adam G Walker, Douglas J Sheffler, et al. · Neuropsychopharmacology · 19

PDF

PCRX-201, a novel IL-1Ra gene therapy treatment approach for low back pain resulting from intervertebral disc degeneration

2024 · Joseph W. Snuggs, Rebecca K. Senter, et al. · Gene Therapy · 10

PDF

A novel gut-restricted small molecule TLR2 agonist enhances immune checkpoint inhibitor efficacy in a preclinical mouse fibrosarcoma tumor model

2022 · J. Simon, C.J. Oalmann, et al. · European Journal of Cancer · 2

PDF

Targeting microbial bile salt hydrolase reprograms bile acid metabolism and ameliorates metabolic dysfunction–associated steatohepatitis in mice

2026 · Wenchao Wei, Radka Graf, et al. · Molecular Metabolism

PDF

Pcrx-201, a Novel Gene Therapy Treatment Approach for Intervertebral Disc Degeneration

2023 · J. Snuggs, R. Senter, et al. · Orthopaedic Proceedings

The rat homolog to FX201, a gene therapy in development for the treatment of osteoarthritis, demonstrates dose-dependent decreases in the severity of cartilage and bone lesions following anterior cruciate ligament transection

2020 · R. Senter, R. Boyce, et al. · Osteoarthritis and Cartilage

PDF

The Therapeutic Potential of mGlu 3 Antagonism in Correcting Hippocampal Long‐term Depression Impairments in a Mouse Model of MECP2 Duplication Syndrome

2016 · Branden Stansley, Rocco Gogliotti, et al. · The FASEB Journal

Works count: 15

Citation count: 415

H-index: 10

I10-index: 10